Modified Quadruplet Regimen Effective in Older Myeloma Patients

(MedPage Today) -- A modified version of the regimen combining the anti-CD38 monoclonal antibody isatuximab (Sarclisa) with bortezomib (Velcade), lenalidomide (Revlimid), and limited dexamethasone was safe and effective for older multiple myeloma...